OGN News and Press, Organon & Co. From 07/08/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Given Organon & Co’s (NYSE: OGN ) low growth, its sizeable competition, its lack of concrete positive catalysts, and the fact that its management plans to institute an average dividend in the future, I urge...

Artur/iStock via Getty ImagesStudies have shown that one of the best predictors of stock price performance is recent performance. In other words, what worked recently is most likely to keep working. So: What worked in June?By style: Piling into aspects of the value strategy and fund...

My Roth IRA portfolio of 29 CEFs and 29 REITs for income, and 124 stocks for swing trading mostly under-performing S&P 500 stocks, continues to realize profits. In June, I closed 6 stock trades for a net gain, including dividends, of 43.33% (median) or 50.47% (cost-weighted), for ...

Organon (NYSE: OGN) has been notified of an unsolicited mini-tender offer by TRC Capital Investment Corporation (“TRC”) to purchase up to 3,000,000 shares of Organon common stock from Organon stockholders, representing approximately 1.18% of the outstanding shares of Organ...

putilich/iStock via Getty Images Organon (OGN) and Merck (MRK) have dropped a case against Microspherix that sought a covenant not to sue from Microspherix. Microspherix and Merck have been embroiled for years in legal proceedings over Merck's (and now Organon's) birth control implant Nexplan...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It doesn’t make sense, really. Organon  (NYSE: OGN ) was recently spun off from pharmaceutical giant Merck  (NYSE: MRK ), so you’d think Wall Street would be buzzing about OGN stock. So...

In its first earnings report as a separately traded company from Merck (MRK), Organon (OGN) reiterated a forecast made in early May that its sees full year 2021 revenue of between $6.1B and $6.4B.The company also sees adjusted EBITDA margin in a range of 36% to 38%.The revenue forecast, howev...

Organon (OGN): Q1 GAAP EPS of $1.58.Revenue of $1.51B (-15.2% Y/Y)Shares +0.73% PM.Press Release For further details see: Organon reports Q1 results

Company affirms guidance provided during May 3 rd Investor Day; will host second quarter earnings call on or about August 12, 2021 Organon (NYSE: OGN) (the “company”), today announced that it has filed a Form 10-Q for the quarter ended March 31, 2021. In th...

Organon (NYSE: OGN), a global women’s healthcare company, today announced the completion of its acquisition of Alydia Health, a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or abnormal postpar...